FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078677532> ?p ?o ?g. }

• W2078677532 endingPage "1422" @default.
• W2078677532 startingPage "1411" @default.
• W2078677532 abstract "Polycythemia vera (PV) is characterized by erythrocytosis associated with the presence of the activating JAK2(V617F) mutation in a variable proportion of hematopoietic cells. JAK2(V617F) is detected in other myeloproliferative neoplasms, does not appear to be the PV-initiating event, and its specific role in deregulated erythropoiesis in PV is incompletely understood. We investigated the pathogenesis of PV to characterize abnormal proliferation and apoptosis responses and aberrant oncogenic pathway activation in primary PV erythroid precursors.Peripheral blood CD34(+) cells isolated from PV patients and healthy controls were grown in liquid culture to expand a population of primary erythroblasts for experiments designed to analyze cellular proliferation, apoptosis, JAK2(V617F) mutation status, cytokine-dependent protein phosphorylation and gene expression profiling using Affymetrix microarrays.The survival and proliferation of PV erythroblasts were growth factor-dependent under strict serum-free conditions requiring both erythropoietin (EPO) and stem cell factor. PV erythroblasts exhibited EPO hypersensitivity and enhanced cellular proliferation associated with increased EPO-mediated extracellular signal-regulated kinases 1 and 2 phosphorylation. EPO-induced AKT phosphorylation was observed in PV but not normal erythroblasts, an effect associated with apoptosis resistance in PV erythroblasts. Analysis of gene expression and oncogenic pathway activation signatures revealed increased RAS (p<0.01) and phosphoinositide-3 kinase (p<0.05) pathway activation in PV erythroblasts.Deregulated erythropoiesis in PV involves EPO hypersensitivity and apoptosis resistance of erythroid precursor cells associated with abnormally increased activation of RAS-ERK and phosphoinositide-3 kinase-AKT pathways. These data suggest that investigation of the mechanisms of abnormal RAS and phosphoinositide-3 kinase pathway activation in erythroblasts may contribute to our understanding of the molecular pathogenesis of PV." @default.
• W2078677532 created "2016-06-24" @default.
• W2078677532 creator A5019414694 @default.
• W2078677532 creator A5040437190 @default.
• W2078677532 creator A5048770508 @default.
• W2078677532 creator A5049711954 @default.
• W2078677532 creator A5070853337 @default.
• W2078677532 creator A5074780126 @default.
• W2078677532 date "2009-12-01" @default.
• W2078677532 modified "2023-09-26" @default.
• W2078677532 title "Polycythemia vera erythroid precursors exhibit increased proliferation and apoptosis resistance associated with abnormal RAS and PI3K pathway activation" @default.
• W2078677532 cites W1544350757 @default.
• W2078677532 cites W1703848171 @default.
• W2078677532 cites W176998439 @default.
• W2078677532 cites W1886472157 @default.
• W2078677532 cites W1972927903 @default.
• W2078677532 cites W1974452880 @default.
• W2078677532 cites W1980568348 @default.
• W2078677532 cites W1987470267 @default.
• W2078677532 cites W1988610058 @default.
• W2078677532 cites W1990250202 @default.
• W2078677532 cites W1997560018 @default.
• W2078677532 cites W2002782759 @default.
• W2078677532 cites W2003988449 @default.
• W2078677532 cites W2005831731 @default.
• W2078677532 cites W2009857536 @default.
• W2078677532 cites W2010337187 @default.
• W2078677532 cites W2020562174 @default.
• W2078677532 cites W2024591653 @default.
• W2078677532 cites W2027057993 @default.
• W2078677532 cites W2038195476 @default.
• W2078677532 cites W2046160400 @default.
• W2078677532 cites W2049145190 @default.
• W2078677532 cites W2051066066 @default.
• W2078677532 cites W2056154856 @default.
• W2078677532 cites W2057360098 @default.
• W2078677532 cites W2058451329 @default.
• W2078677532 cites W2061912403 @default.
• W2078677532 cites W2062984099 @default.
• W2078677532 cites W2065063478 @default.
• W2078677532 cites W2070658555 @default.
• W2078677532 cites W2075379915 @default.
• W2078677532 cites W2076153728 @default.
• W2078677532 cites W2088471767 @default.
• W2078677532 cites W2093014059 @default.
• W2078677532 cites W2094457899 @default.
• W2078677532 cites W2100869656 @default.
• W2078677532 cites W2102163954 @default.
• W2078677532 cites W2103079856 @default.
• W2078677532 cites W2105949419 @default.
• W2078677532 cites W2106571571 @default.
• W2078677532 cites W2107515803 @default.
• W2078677532 cites W2126665281 @default.
• W2078677532 cites W2156482024 @default.
• W2078677532 cites W2162013503 @default.
• W2078677532 cites W2166709785 @default.
• W2078677532 cites W2169501631 @default.
• W2078677532 cites W2337577525 @default.
• W2078677532 cites W2395600057 @default.
• W2078677532 cites W32931231 @default.
• W2078677532 cites W4237200993 @default.
• W2078677532 cites W4249832396 @default.
• W2078677532 doi "https://doi.org/10.1016/j.exphem.2009.09.009" @default.
• W2078677532 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2783925" @default.
• W2078677532 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19815050" @default.
• W2078677532 hasPublicationYear "2009" @default.
• W2078677532 type Work @default.
• W2078677532 sameAs 2078677532 @default.
• W2078677532 citedByCount "38" @default.
• W2078677532 countsByYear W20786775322012 @default.
• W2078677532 countsByYear W20786775322013 @default.
• W2078677532 countsByYear W20786775322014 @default.
• W2078677532 countsByYear W20786775322015 @default.
• W2078677532 countsByYear W20786775322017 @default.
• W2078677532 countsByYear W20786775322018 @default.
• W2078677532 countsByYear W20786775322019 @default.
• W2078677532 countsByYear W20786775322020 @default.
• W2078677532 countsByYear W20786775322021 @default.
• W2078677532 countsByYear W20786775322022 @default.
• W2078677532 crossrefType "journal-article" @default.
• W2078677532 hasAuthorship W2078677532A5019414694 @default.
• W2078677532 hasAuthorship W2078677532A5040437190 @default.
• W2078677532 hasAuthorship W2078677532A5048770508 @default.
• W2078677532 hasAuthorship W2078677532A5049711954 @default.
• W2078677532 hasAuthorship W2078677532A5070853337 @default.
• W2078677532 hasAuthorship W2078677532A5074780126 @default.
• W2078677532 hasBestOaLocation W20786775322 @default.
• W2078677532 hasConcept C109159458 @default.
• W2078677532 hasConcept C126322002 @default.
• W2078677532 hasConcept C134018914 @default.
• W2078677532 hasConcept C184235292 @default.
• W2078677532 hasConcept C190283241 @default.
• W2078677532 hasConcept C203014093 @default.
• W2078677532 hasConcept C2778248108 @default.
• W2078677532 hasConcept C2778534260 @default.
• W2078677532 hasConcept C2778837598 @default.
• W2078677532 hasConcept C2779703530 @default.
• W2078677532 hasConcept C28328180 @default.

• next